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Abstract
Objective The aim of this study was to determine the effect of
an oxygenatingmouthwash compared to two other established
mouthwash products on bacterial composition and metabolic
activity of oral biofilms in vitro.
Material and methods Twelve healthy subjects participated as
donors. Plaque-saliva mixture inoculated biofilms were grown
and treated with 3 different chemotherapeutic mouthwashes
[amine fluoride/stannous fluoride (MD), oxygenating agent
(AX), chlorhexidine 0.12 % (PA), and water (W)]. Effects of
treatments were assessed on biofilm composition (16S rRNA
gene amplicon sequencing), production of organic acids (for-
mate, acetate, lactate, propionate, butyrate using capillary
electrophoresis), and viability of the remaining biofilm
(CFUs).
Results Microbial profiles of biofilms clustered per inoculum
donor and were dominated by the genera Veillonella,
Streptococcus, and Prevotella. Microbial diversity was only
reduced after PA treatment. Significant changes in composi-
tion occurred after treatment with AX, resulting in lower pro-
portions of Veillonella and higher proportions of non-mutans
streptococci. Production of all organic acids after PA and lac-
tate after MD was significantly lower as compared to W. AX
resulted in reduction of acetate, butyrate, and propionate and
increase in lactate production (p < 0.05). Viable counts were
significantly lower after PA and AX treatments compared to
W, while no significant reduction was observed after MD.
Conclusions All studied mouthwashes affected the in vitro
biofilms differently. The effects of the AX treatment were
the most prominent which resulted in changes of the bacterial
composition and metabolism.
Clinical implications Awareness by the dental team that
mouthwashes can change the bacterial composition and me-
tabolism is important when advising its use.
Keywords Biofilm .Microcosm . Organic acids .
Mouthwashes . Antimicrobials
Introduction
Dental plaque biofilms are communities of microbial cells in
the oral cavity that are embedded in an extracellular polymeric
matrix. Oral biofilms are among the most complex microbial
communities in nature. Dental plaque affects all humans
worldwide. Failure to deal with plaque in the early stage of
formation may lead to the development of oral diseases of
which the most prevalent are dental caries, gingivitis, and
periodontitis [1]. Since the mouth is the gateway to the human
body, establishing and maintaining oral health is important.
Various strategies have been employed to reduce or
eliminate dental biofilms. Mechanical disruption of dental
plaque biofilms such as toothbrushing is worldwide the
most common approach. The effectiveness of this is how-
ever limited [2, 3]. Therefore, also chemotherapeutic strat-
egies to disrupt these biofilms have been considered, such
as the use of mouthwashes. Over the past decades, the use
of these has become customary, usually following me-
chanical plaque biofilm control [4].
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Currently, there is a wide range of over the counter
mouthwashes products available, containing various ac-
tive ingredients with for each of these specific indica-
tions. It is the role of the dental teams to advice the use
of mouthwashes when indicated, which is justified when
its efficacy has been proven by studies based on clinical
evidence.
A recent meta-review [4] has shown that, to date, the
scientific body of evidence for the use of specific agents
such as chlorhexidine is substantial. However, for most
commercially available mouthwashes, the scientific evidence
is considered to be moderate, weak, or underreported. For
instance, the underlying data retrieved in a systematic review
for oxygenating agents (OAs) did not allow for a meta-
analysis [5].
Serrano and colleagues [6] have analyzed the scientific
evidence for the efficacy of adjunctive anti-plaque chemical
agents in managing gingivitis. These authors concluded that
the use of specific agents showed statistically significant im-
provements in terms of gingival, bleeding and plaque indices.
OAs were not included in their meta-analysis.
Nevertheless, most mouthwashes, among which also
OAs, are available without a prescription and their use
is a common practice. Oxygenating agents, such as hydro-
gen peroxide (H2O2), buffered sodium peroxyborate, and
peroxycarbonate, have been recommended for short-term
use as disinfectants [4, 5]. Recently a mouthwash contain-
ing an oxygenating agent (peroxoborate) has been intro-
duced in the market and the result of a pilot study has
shown that this product has the potential for selective
inhibition of oral bacteria. Twice-daily exposure for
1 week to this mouthwash resulted in a shift in the micro-
bial composition towards a less diverse and less mature
plaque [7].
Oral microbes contribute to the healthy homeostasis
within the oral cavity [8]. Therefore, besides addressing
a clinical efficacy of a mouthwash, it is important to in-
vestigate its effects on the oral microbiome [9]. For this
purpose, in vitro biofilm models offer an approach to elu-
cidate the microbiological and ecological effect of poten-
tial products at an early stage of product development
[10–15].
The aims of this study were to assess and determine
the effect of an oxygenating mouthwash compared to
two other established and commercially available
mouthwashes products and a negative water control on
the bacterial composition and metabolic activity of oral
biofilms in vitro.
The null hypothesis was that the treatment effect of an
oxygenating and a fluoride-based mouthwash will not differ
in terms of bacterial composition and metabolic activity than
compared to a negative control (water) or a positive control
(chlorhexidine).
Material and methods
Selection of inoculum donors
Twelve individuals participated as donors of saliva and dental
plaque after reading and signing an informed consent form.
All donors were in good general health and had not been
exposed to antibiotics and professional dental prophylaxis
within the previous 3 months. Exclusion criteria were visible
caries or a Dutch periodontal screening index (DPSI) of small-
er or equal to score 3 minus (which translates to periodontal
pockets ≤5mm in absence of gingival recession) [16]. Prior to
sample collection, subjects were asked not to perform any
oral hygiene 24 h before the appointment and to refrain
from any food or drink consumption for at least 2 h before
sampling [17].
Ethical approval of the protocol related to plaque-saliva
collection and experimental research was provided by the
Medical Ethical Committee from the Vrije Universiteit
Medical Center Amsterdam (reference 2011/236).
Sampling
Sampling took place in the morning between 08:30 and 09:30.
Supragingival dental plaque was collected with sterile plastic
curettes along the gingival margin of all buccal and lingual
surfaces in the second and fourth quadrants. The samples were
placed in a previously weighed Eppendorf vial containing
100 μl of cysteine peptone water (CPW), vortexed for 30 s,
and briefly centrifuged. Then, the vials were weighed again
and the difference in weight was calculated. CPW was added
normalizing to a proportion of 10 mg plaque: 1.3 ml CPWand
stored on ice. Subsequently, participants chewed on a piece of
a parafilm for 1 min. Approximately 1 ml of -stimulated saliva
was collected in a sterile universal vial being kept on ice.
Biofilm model and production of the biofilms
An active attachment biofilm model was used as previously
described [11]. In brief, 24-well polystyrene culture plates
(Greiner Bio-One, Alphen a/d. Rijn, the Netherlands) were
used. The lid of the plate was replaced by a custom-made
stainless-steel lid, onto which 24 nylon clamps were fixed
allowing for various substrata to be inserted. The clamps were
positioned in such a way that the inserted substrata would fit
into the wells of the culture plate. Since the substrata were
positioned vertically, bacterial attachment plays a key role in
this model. By transferring the lid with the substrata to a new
plate, the medium could be refreshed. In this study, standard-
ized 12-mm hydroxyapatite (HA) disks (Himed, Old
Bethpage, USA) were used as substratum. The assembled
model was autoclaved at 121 °C.
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McBain medium [18] with 50 mmol/l PIPES at pH 7 [19]
was used. After autoclaving, the medium was supplemented
with filter-sterilized 0.2 % sucrose and sterile heat-inactivated
5 % fetal bovine serum (FBS, F4135, Sigma-Aldrich, USA).
The suspension of dental plaque samples was dispersed
using a sonicator (Vibra Cell, Sonics & Materials Inc.,
Newtown, CT) for 3 s with 1-s pulses at amplitude of 40 W
and vortex-mixing for 30 s just before inoculation. The inoc-
ulation medium was immediately prepared using a mixture of
dental plaque 1:15 (1.25 ml of suspension in 20 ml of CPW)
and saliva 1:50 (0.4 ml of saliva in 20 ml of CPW) as inocu-
lum. Next 1.5 ml of the inoculation medium was added to
each well of a standard polystyrene 24-well plate (multiwell
p la tes ; Gre iner Bio One, Alphen aan den Ri jn ,
The Netherlands). For each donor, an individual plate was
used. The model was subsequently incubated anaerobically
(10 % CO2, 10 % H2, and 80 % N2) at 37 °C. After an initial
24 h of incubation, the medium was refreshed with sterile
medium twice a day based on a schedule of 8 and 16 h, up
to 96 h.
To analyze the bacterial composition of the inocula, 100 μl
of the plaque-saliva suspension was stored at −20 °C for DNA
extraction and analysis.
Treatment of the biofilms
After 96 h, the biofilms were treated by transferring them to a
new plate containing the treatment solution (1.8 ml/well) for
10 min at room temperature with one of the following
compounds:
1. Perioaid® (Dentaid Benelux, Houten, the Netherlands)
containing 0.12 % chlorhexidine (PA).
2. Meridol® (GABA International, Basel, Switzerland), an
amine fluoride/stannous fluoride (AmF/SnF2)-containing
mouthwash (MD).
3. Ardox-X-technology®, commercially known as O7-
active (NGen Oral Pharma N.V., Curacao) an oxygenat-
ing agent (AX).
4. Sterile demineralized water as a negative control.
Triplicate biofilms were treated with the abovementioned
compounds and a negative water control resulting in four
treatment groups for each donor.
Following treatment, biofilms were rinsed with CPW
(1.9 ml/well) moving the lid 10 times up and down in the plate
[19]. This rinsing procedure was repeated 3 times with fresh
CPW to remove excess treatment solution.
Biofilm incubation for acid formation
Subsequently, the lid was placed on a plate containing 1.5 ml
buffered peptone water (BPW) with 0.2 % sucrose per well
and incubated anaerobically for 3 h at 37 °C. After the incu-
bation, BPW was collected and stored at −80 ° C.
Harvesting of the biofilms
Each HA disk with biofilm was removed using sterile forceps
and placed in a sterile vial containing 2 ml of phosphate-
buffered saline (PBS). All samples were kept on ice, dispersed
by sonication for 2 min at 1 s pulsations at the amplitude of
40W (Vibra Cell; Sonics &Materials Inc., Newtown, CT) and
vortexed for 30 s.
Determination of number of CFUs
Serial dilutions of the dispersed biofilms in PBS were made
and plated on trypticase soy agar blood (TSAB) plates for total
viable counts. The plates were incubated for 7 days at 37 °C
under anaerobic conditions (10 % CO2, 10 % H2, and
80 % N2), and the number of colony-forming unit (CFU)
counts was determined.
Propidium monoazide (PMA) treatment
To assure that only DNA from the cells with intact membranes
(undamaged cells) was processed for sequencing, the dis-
persed biofilms were treated with PMA as described previous-
ly [19]. In brief, 2.5 μl PMA (Biotum Inc., Hayward, Calif.,
USA) was added to 500 μl suspended biofilm, incubated in
the dark for 5 min, and then exposed to intense light for 2 min
using a 650 W halogen lamp placed 25 cm from the samples.
The samples were kept on ice during this procedure.
Organic acid analysis
The concentration of organic acids in BPW following incuba-
tion with sucrose was determined by capillary electrophoresis
(Waters Capillary Ion Analyzer Milford, Mass, USA) as de-
scribed previously [20]. As an internal standard, 0.12 mmol/l
oxalate was included in all samples. Succinate, formate, ace-
tate, lactate, propionate, and butyrate were determined and
expressed as mmol acid/disk. The total concentration of acid
excreted by the biofilms to the environment (BPW) was cal-
culated as the sum of all acids per biofilm.
DNA extraction, amplicon preparation, and sequencing
data analysis
DNA from the inocula and biofilms was extracted as previ-
ously described [21]. Barcoded amplicon libraries of the small
subunit ribosomal RNA gene hypervariable region V5–V7
were generated for each of the individual samples, pooled
and sequenced using Genome Sequencer FLX Titanium sys-
tem (Roche, Basel, Switzerland) as described previously [22].
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The sequencing data were processed using Quantitative
Insights Into Microbial Ecology (QIIME) [23] version 1.5.0
as described previously [22].
To allow comparisons among different samples, the dataset
containing Operational Taxonomic Units (OTUs) was ran-
domly subsampled at an equal depth. Hierarchical clustering
based on the Bray-Curtis similarity index (BC) was used to
assess the similarities among the biofilms per group—a non-
linear coefficient between every pair of OTUs. Shannon di-
versity index was calculated, which takes into account the
abundance of each OTU, as well as the number of OTUs. To
visualize microbial profile data, non-metric multidimensional
plots (n-MDS) based on the BC were used.
In addition, taxonomy of the representative sequences of
the most abundant OTUs was identified by microbial nucleo-
tide BLAST search against a Human Oral Microbiome
Database (HOMD) reference set (version 13.2). The possible
alternatives for the species identification were then provided.
Statistical analysis
Statistical analyses were performed on median values of trip-
licate biofilm data. Non-metric multidimensional scaling
(nMDS) plots were based on the Bray-Curtis coefficient to
visualize similarity between samples. Stress <0.2 (Kruskal’s
stress formula 1) was used as an acceptable threshold [24].
Similarity percentage (SIMPER) was used to identify the
OTUs with the highest contribution to dissimilarity between
the treatments. The differences in composition between
treatment groups were assessed using one-way permuta-
tional multivariate analysis of variance (PERMANOVA).
The p values were corrected for multiple comparisons
using Bonferroni correction. p values <0.05 were consid-
ered statistically significant. All calculations were per-
formed using PAST version 3.0 [25].
The software package IBM SPSS Statistics version 20.0
(2011, IBM Corp., Armonk, NY, USA) was used to perform
all other statistical analyses. For comparisons among the treat-
ment groups based on CFU counts, the median of triplicate
biofilms was calculated, based on which the percentage of the
remaining biofilm relative to the water-treatment was deter-
mined. Almost all groups were normally distributed (Shapiro-
Wilk test) except for the AX group. Pairwise comparisons
were performed using Paired sample t tests, and corrected
for multiple comparisons using Bonferroni corrections.
Differences among the organic acid profiles per treatment
group were analyzed regardless of the donor using one-way-
ANOVAwith Games-Howel post-hoc test; p value corrected
for multiple comparisons. Additionally, in order to determine
relationships between the concentration of organic acids and
the relative abundance of the most abundant genera (Table 1),
a Pearson correlation was calculated.
For the comparisons of mouthwashes in relation to the
bacterial composition, only the most abundant genera (on av-
erage, contributing to 94 % of reads in the water-treated
biofilms) were selected. Based on their distribution (Shapiro-
Wilk test), the paired t test or the Wilcoxon Rank test was
used.
Results
Of the 12 participants that donated dental plaque and saliva, 7
were female and 5 were male with an age range of 22–
45 years. One participant was a smoker of <10 cigarettes/
day (donor 4).
The relative abundance of bacterial genera in the inocula
differed to a large extent by donor (Fig. 1). Themean Shannon
diversity index of the inocula (3.05; SD 0.3) was significantly
higher (p < 0.01) than the mean diversity index of the 96 h
water-treated (W, negative control) biofilms (1.57; SD 0.5).
Table 1 The relative proportion at genus level per mouthwash
compared to the water treatment (n = 12)
Genus (OTU ID) Mean % SD p value
Veillonellaa (OTU 190) Water 62.2 (10)
MD 64.2 (10) 0.081
PA 68.0 (10) 0.034
AX 48.2 (20) 0.030
Streptococcusa (OTU 20) Water 15.6 (10)
MD 11.4 (5) 0.001c
PA 11.1 (4) 0.002
AX 28.7 (10) 0.004
Prevotellab (OTU 296) Water 14 (10)
MD 10.9 (4) 0.084
PA 7.8 (4) 0.008
AX 8.7 (4) 0.010
Parvimonasb (OTU 133) Water 2.1 (2)
MD 2.6 (2) 0.099
PA 3.2 (3) 0.075
AX 4.2 (4) 0.015
Solobacteriumb (OTU 6) Water 1.9 (2)
MD 1.3 (1) 0.050
PA 0.9 (1) 0.002
AX 0.8 (0) 0.010
Megasphaerab (OTU 88) Water 1.5 (1)
MD 1.3 (1) 0.023
PA 0.7 (1) 0.002
AX 0.4 (0) 0.002
a Paired t test
bWilcoxon rank test (p values not corrected for multiple comparisons)
c p values (highlighted in bold) that remain significant after Bonferroni
correction for multiple tests
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All biofilms were dominated by genus Veillonella (OTU
190), Streptococcus (OTU 20), and Prevotella (OTU 296).
These OTUs were blasted against a HOMD database for
species-level taxonomical classification. Veillonella (OTU
190) was identified as Veillonella dispar (HOT 160)/
Veillonella rogosa (HOT 158) at 99.7 % blast ID and as
Veillonella atypica (HOT 524) / Veillonella parvula (HOT
161) at 99.7 % blast ID. V. parvula is phylogenetically similar
to V. dispar; however, V. parvula is catalase negative whereas
V. dispar is catalase positive.
Streptococcus (OTU20) was identified as Streptococcus
oralis (HOT 707) 100 % blast ID and as Streptococcus spe-
cies (HOT 071; HOT 070; HOT 064 and HOT 058) 100 %
blast ID. OTU 296 was ident i f ied as Prevotel la
melaninogenica (HOT 469) 100 % blast ID.
The hierarchical classical cluster analysis based on the
Bray-Curtis similarity index among the biofilm triplicates
showed that replicate biofilms clustered together (data not
shown).
The water-treated biofilms showed variability among do-
nors in relative abundance of the genera Veillonella,
Streptococcus, Megasphaera, Peptostreptococcus, and
Prevotella (Fig. 2). Veillonella was the most abundant genus
(40–87 % of reads), followed by Streptococcus (3–27 %), and
Prevotella (3–27 %) with 4–20 % of the reads belonging to
other genera.
Ten-minute treatment with different compounds resulted in
compositional changes in the remaining biofilm. As compared
to the W-treated biofilms, the PA treatment resulted in a sig-
nificantly lower diversity index (1.32, SD 0.4) compared to
W-treated biofilms 1.57 (SD 0.5). The relative abundance of
the genus Streptococcus, Solobacterium, and Megasphaera
was significantly lower in the PA-treated biofilms compared
to the water control (Table 1, Fig. 2).
The diversity index for the MD treated biofilms (1.52, SD
0.4) was not statistically different from the water control. The
relative abundance of genus Streptococcus was statistically
lower in the MD-treated biofilms than in the water control
(Table 1, Fig. 2).
Also, AX treatment had no significant effect on diversity
index (1.62, SD 0.4) in the biofilms. However, genus
Megasphaera was significantly lower in the AX-treated
biofilms compared to the water control (Table 1, Fig. 2).
In order to assess the dissimilarities between the treatment
groups, we used the non-metric multidimensional scaling (n-
MDS). This analysis showed that the dissimilarities among the
treatment compounds were statistically significant only when
AX-treated biofilms were compared to PA or MD treated
biofilms (p ≤ 0.05) (Fig. 3).
The effect of each of the tested compounds on the compo-
sition of the remaining biofilms had a clear pattern (Fig. 2).
Variability among the biofilms originating from different do-
nors was visually observed on a 3D plot. In particular, the
respective samples from donors 8 and 11 clustered close to-
gether regardless the treatment group (Fig. 3). In contrast,
biofilms from donors 2, 4, 6, 7, and 9 revealed a clear effect
of the AX treatment (squares at the left side of the plot) except
from donor 10 (square at the right side of the plot). The W-
treated biofilms and AX-treated biofilms clustered close to-
gether in donors 1, 3, and 5.
Treatment effect on viable counts
W-treated biofilms yielded comparable average total viable
counts (5.9x109 CFUs/biofilm, SD 9x109) among all donors
(p = 0.176). Compared to the W-treated control, the percent-
age of remaining biofilm observed as viable counts after PA
treatment was 57% (SD 16) and after AX treatment 40% (SD
Fig. 1 Relative abundance of the
major bacterial genera in the
inoculum (plaque-saliva mixture)
per donor. Others—the sum of the
remaining taxa
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14). This difference was statistically significant for both PA
and AX treatment (p < 0.05). After MD treatment viable
counts were not significantly lowered, the percentage remain-
ing viable cell counts was 76 % (SD 35) relative to the W-
treated control (Fig. 4).
Organic acids
The concentration of succinate in biofilms was low and sim-
ilar for all groups (data not shown). PA-treated biofilms had
statistically significantly lower amounts of formate, lactate,
propionate, and acetate compared to water-treated biofilms
after a 3-h incubation with sucrose, whileMD-treated biofilms
had significantly lower lactate compared toW-treated biofilms
(Fig. 5). In contrast, AX-treated biofilms had a significantly
higher amount of lactate and significantly lower amounts of
acetate, propionate, and butyrate (p ≤ 0.001). A positive cor-
relation between the relative abundance of genus Veillonella
and the sum of acetate and propionate (Pearson r = 0.7) ex-
creted to the environment (BPW) was only observed for AX-
treated biofilms.When all measured acids were added, PA had
a significantly lower amount of total acid than the water
control.
Discussion
In this study, an established microcosm biofilm model was
used that allows studying the effects of mouthwashes from a
microbiological and ecological perspective. We demonstrated
that using this biofilm model, a single exposure to a mouth-
wash product resulted in different patterns in terms of bacterial
composition and metabolic activity of the microcosm biofilm,
depending on the chemotherapeutic agent used. Biofilms
treated with AX caused major changes in bacterial composi-
tion, metabolism, and killing effect. This study did however
Fig. 2 Relative abundance of
major bacterial genera per donor
after 10-min treatment with water,
PerioAid (PA), Meridol (MD) or
Ardox-X (AX). The data shown
are median values from triplicate
biofilms
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not evaluate the recovery of the biofilms after a single treat-
ment exposure.
Since the compounds tested in the present study have dif-
ferent mechanisms, we did not attempt to determine the Bbest
antimicrobial^ but to characterize their effect with respect to
bacterial composition of oral microcosms and their metabolic
activity.
While current clinical studies have focused on the amount
of plaque and the severity of gingival inflammation, this study
highlights the importance of studying not only the Bkilling^
capacity of mouthwashes or chemotherapeutic agents, but also
the effect on bacterial composition and metabolic activity The
most striking finding was the high amount of lactic acid pro-
duced after AX-treatment along with a reduction of the CFUs
up to approximately 40 % relative to the water control. This
could be explained by the selective inhibition properties of
this oxygenating compound [7]. This is further supported by
the observation that after AX treatment the relative abundance
of genus Veillonella was significantly lower in the treated bio-
film accompanied with the higher relative proportion of other
genera mainly Streptococcus. Increase of streptococci on the
other hand, is attributable to the proportionality of the data,
because within 10 min, no absolute increase that would imply
bacterial growth is possible. Therefore, the only explanation
for this finding is that relative abundance of genus
Streptococcus increases due to a decrease in other taxa such
as Veillonella.
Veillonella which has an important role in biofilm de-
velopment [26], is a gram-negative bacterium that lacks
glucokinase and fructokinase. It is therefore unable to
Fig. 3 Non-metric
multidimensional scaling
(n-MDS) based on three-
dimensional Bray-Curtis
similarity (p = 0.001,
stress = 0.07, F = 3.76), n = 12.
Colors indicate individual donors.
The donors’ number is shown
next to the water treatment (dot).
Shapes represent a treatment.
Comparisons between groups
were done using one-way
PERMANOVA; W vs AX
p = 0.186; W vs PA p = 0.394; W
vsMD p = 1; PAvsMD p = 1; PA
vs AX p = 0.015; MD vs AX
p = 0.043
Fig. 4 Effect of single treatment on viable counts expressed as a
percentage of the water-treated control is described as the remaining
biofilm. The data shown are the average and standard deviation
(n = 12). Different letters indicate statistically significant differences
between the treatments PerioAid (PA), Meridol (MD) or Ardox-X
(AX). *statistically significant lower amount of remaining biofilms
compared to the water treated control (p ≤ 0.05), paired sample t test,
corrected for multiple comparisons
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metabolize carbohydrates [26] and instead uses lactate as
energy source. The fact that the Veillonella proportion was
significantly reduced could explain the high lactate
amount present in the AX-treated biofilms. These results
are in line with the notion that the interaction of these
genera can affect the metabolic activity reflected in lactate
utilization by biofilms [26], which can potentially affect
microbial community development [27].
Although both, PA- and AX-treatment resulted in a lower
production of propionate, acetate, and butyrate, this effect was
greater for AX-treatment. Butyrate is mainly produced by
proteolytic anaerobic bacteria [28, 29] and has been associated
with the inflammation found in periodontal disease [30]. AX
has the potential to contribute to the treatment of periodontal
diseases by further reducing the concentration of acetic,
propionic, and butyric acid and by increasing the lactic acid
within the GCF. In this way, AX can contribute to the resil-
ience of the subgingival microbiome towards disease. On the
other hand, the possible consequences of the higher concen-
trations of lactate triggered by the AX-treatment need to be
elucidated. When produced by probiotics, lactic acid has been
described as a natural antimicrobial that is beneficial as an
adjunctive to the treatment of periodontitis [31]. Although
the results achieved here with AX are promising, in vivo stud-
ies are needed to assess this potentially beneficial effect on the
non-surgical treatment or in the maintenance of periodontal
diseases.
MD-treatment proved to have the ability to inhibit the lactic
acid formation by the biofilm without significantly reducing
the total viable counts. Our findings that MD significantly
lowered the relative abundance of genus Streptococcus and
the lactate production are in agreement with previous in vitro
studies [11].
In this study, we supplemented the growth medium with
heated inactivated serum. This was to simulate gingivitis,
prevalent in large part of health adult population [2]. Serum
is an important component of the gingival crevicular fluid, and
the use of 5 % serum in the medium may have influenced the
growth of bacteria. Being aware that in the oral environment
there is a continuous interaction between supragingival plaque
and saliva, we have used this mixture as inoculum.
Considering as well, that after a single episode of tooth
brushing, on average plaque scores are reduced by only
42 % the plaque that remains on the tooth surfaces [2] will
lead to a recolonization of the cleaned areas.
Using the same biofilm model as in the present study, a
recent paper describes using saliva from a single donor as
inoculum for the production of biofilms, with an initial incu-
bation period of 8 h and a total incubation period of 48 h [19].
It was observed that the composition of the water-treated con-
trol biofilms (PMA treated) was dominated by genera
Streptococcus (62 %), Veillonella (35 %), and Prevotella
(2 %). In the present study, we attempted to increase the di-
versity of the biofilms by using as inoculum source a mixture
of saliva and dental plaque. Furthermore, we increased the
incubation period to 24 h and the total incubation period to
96 h, providing time to the slow-growing bacteria to establish
within the biofilms. Figure 2 illustrates the relative abundance
of the biofilms per donor being the water-treated control
biofilms dominated by genera Veillonella, Streptococcus,
Megasphaera, Peptostreptococcus, and Prevotella with 4–
20 % of the reads belonging to other genera.
Rudney and collaborators [13] have shown that repeated
plaque or saliva inoculums taken on different weeks, from the
same donor, clustered together, suggesting that the microbial
composition of the biofilms was consistent within subjects
Fig. 5 Effect of single treatment
on organic acids after a 3-h
incubation with 0.2 % sucrose
following the respective 10-min
treatment of plaque-saliva
mixture-derived biofilms. The
sum of all acids is represented as
total. Different letters indicate
statistically significant differences
between the treatments (p < 0.05,
one-way-ANOVA, Games-
Howel test; p value corrected for
multiple comparisons) per anion
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over time. The authors have shown that microcosms were
relatively stable within subjects over time, but there clearly
were differences in species composition between subjects.
Subsequently we decided to use multiple donors.
Regarding the variability among donors, it was not only
biofilms from the same donor that clustered together, but also
the bacterial profiles after the mouthwash treatment. In partic-
ular, biofilms derived from donor 11 (Fig. 2) seemed not to be
affected by any mouthwash agent as compared to the water
treatment. Also where donor 10 had minor changes after PA
and MD treatment, it seemed not to be affected by AX as
compared to water treatment. Our results confirmed the vari-
ation among donors in in vitro biofilms and are in agreement
with previous studies [12, 32–34]. Our study supports the
notion that pooling samples and averaging the data can mask
the individual variability of results of the treatment and the
conclusions that are based on them [32, 33]. The differences
observed between the biofilms and their inoculum source are
in agreement with previous in vitro studies [34, 35].
A recent study has shown differences in bacterial compo-
sition at the site level [36]. Whether these differences found in
vivo will lead to different microcosms derived from specific
niches, and with-in or between donors still needs to be inves-
tigated. It is plausible that individual samples from certain
sites in a given individual will lead to different results in bac-
terial composition.
A limitation of our study is that we assessed the effects of a
single exposure to mouthwashes, whereas multiple exposures
to a chemotherapeutic compound in vitro are known to lead to
different results in viability [37]. This could explain in part, why
in a previous clinical study we observed different changes in
bacterial composition after twice-daily exposures for a week to
AX [7]. Oxygenating agents such as AX are on the market
while scientific evidence for their use is underreported [4].
Therefore, we underline the need of long-term randomized con-
trolled trials testing these compounds. Concerning Badjunctive^
compounds for plaque and gingivitis control such as AX, the
American Dental Association (ADA) requires an evaluation
period of at least 4 weeks (ADA 1997, 2008) and for mouth-
wash products, an evaluation period of 6 months.
All studied mouthwashes affected the in vitro biofilms dif-
ferently. The effects of the AX treatment were the most prom-
inent which resulted in changes of the bacterial composition,
metabolism, and in addition affected viability.
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